Your browser doesn't support javascript.
loading
Variable Response to ALK Inhibitors in NSCLC with a Novel MYT1L-ALK Fusion.
Tsou, Terrence C; Gowen, Kyle; Ali, Siraj M; Miller, Vincent A; Schrock, Alexa B; Lovly, Christine M; Reckamp, Karen L.
Afiliación
  • Tsou TC; City of Hope Comprehensive Cancer Center, Duarte, California.
  • Gowen K; Foundation Medicine, Inc., Cambridge, Massachusetts.
  • Ali SM; Foundation Medicine, Inc., Cambridge, Massachusetts.
  • Miller VA; Foundation Medicine, Inc., Cambridge, Massachusetts.
  • Schrock AB; Foundation Medicine, Inc., Cambridge, Massachusetts.
  • Lovly CM; Vanderbilt University Medical Center, Nashville, Tennessee.
  • Reckamp KL; City of Hope Comprehensive Cancer Center, Duarte, California. Electronic address: kreckamp@coh.org.
J Thorac Oncol ; 14(2): e29-e30, 2019 02.
Article en En | MEDLINE | ID: mdl-30683295
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: J Thorac Oncol Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: J Thorac Oncol Año: 2019 Tipo del documento: Article